Ernexa Therapeutics Inc. short interest in 2021
In 2021, Ernexa Therapeutics Inc.'s disclosed short interest ran from 2.07% of shares outstanding on 15 Jan 2021 to 3.88% on 31 Dec 2021, a change of +1.81 percentage points. The year's high was 63.35% on 30 Jul 2021 and its low 1.30% on 15 Oct 2021, averaging 10.46% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.38 days on 31 Dec 2021. Full history: Ernexa Therapeutics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 2.07% (15 Jan 2021)
- End of year
- 3.88% (31 Dec 2021)
- Change
- +1.81 pp
- High
- 63.35% (30 Jul 2021)
- Low
- 1.30% (15 Oct 2021)
- Average
- 10.46%
- Highest days to cover
- 3.38 (31 Dec 2021)
- SEC filings marked
- 5
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 2.07% | 1.00 | |
| 12 Feb 2021 | 3.80% | 1.00 | |
| 26 Feb 2021 | 2.08% | 1.00 | |
| 15 Mar 2021 | 5.64% | 1.00 | 10-K filed |
| 15 Jun 2021 | 12.32% | 1.00 | 10-Q filed |
| 30 Jun 2021 | 29.32% | 1.00 | |
| 15 Jul 2021 | 49.48% | 1.00 | |
| 30 Jul 2021 | 63.35% | 1.32 | |
| 13 Aug 2021 | 2.67% | 1.49 | 10-Q filed |
| 31 Aug 2021 | 2.08% | 1.13 | results (8-K) |
| 15 Sep 2021 | 1.46% | 1.00 | |
| 30 Sep 2021 | 1.62% | 1.00 | |
| 15 Oct 2021 | 1.30% | 1.25 | |
| 29 Oct 2021 | 1.46% | 1.93 | |
| 15 Nov 2021 | 1.33% | 1.35 | 10-Q filed |
| 30 Nov 2021 | 1.58% | 1.22 | |
| 15 Dec 2021 | 2.92% | 2.62 | |
| 31 Dec 2021 | 3.88% | 3.38 |
See also: Ernexa Therapeutics Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.